You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Updates in Atopic Dermatitis From the Spring Allergy Meeting

  • Authors: Robert Sidbury, MD, MPH; Peter A. Lio, MD
  • CME Released: 8/28/2020
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 8/28/2021
Start Activity


Target Audience and Goal Statement

This activity is intended for dermatologists, allergists & clinical immunologists, primary care physicians, nurse practitioners, and physician assistants.

The goal of this activity is to educate physicians on the latest and emerging clinical data on the treatment of atopic dermatitis (AD) and the importance of treatment selection according to specific patient factors to improve patient care.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Updated clinical evidence for currently available treatments for moderate to severe AD
    • Clinical trials for emerging targeted treatments for moderate to severe AD 
  • Demonstrate greater confidence in their ability to
    • Incorporate AD treatments according to patient-specific factors (eg, age, comorbidities, disease severity)


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Robert Sidbury, MD, MPH

    Professor of Pediatrics
    Chief
    Division of Dermatology
    Seattle Children's Hospital
    Seattle, Washington

    Disclosures

    Disclosure: Robert Sidbury, MD, MPH, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Micreos
    Received grants for clinical research from: Brickell Biotech, Inc.; Galderma Laboratories, L.P.; Regeneron Pharmaceuticals, Inc.

  • Peter A. Lio, MD

    Clinical Assistant Professor of Dermatology and Pediatrics
    Northwestern University Feinberg School of Medicine
    Chicago, Illinois

    Disclosures

    Disclosure: Peter A. Lio, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie Inc.; Amyris; AOBiome; Arbonne International, LLCI; Bodewell; Burt's Bees; Dermavant Sciences, Inc.; Dermira Inc.; Exeltis; Franklin BioScience/Altus; Kiniksa Pharmaceuticals, Ltd.; IntraDerm; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; La Roche Posay/L'Oreal; LEO Pharma Inc.; Level Ex; Lilly USA, LLC; Menlo Therapeutics; Micreos; Pfizer Inc.; Pierre-Fabre; Realm Therapeutics; Regeneron Pharmaceuticals, Inc./Sanofi Genzyme; Theraplex; TopMD; UCB Pharma, Inc.; Unilever United States, Inc.; Verrica Pharmaceuticals
    Served as a speaker or a member of a speakers bureau for L'Oreal; Pfizer Inc.; Regeneron Pharmaceuticals, Inc./Sanofi/Genzyme
    Received grants for clinical research from: AbbVie Inc.; Regeneron Pharmaceuticals, Inc./Sanofi Genzyme
    Owns stock, stock options, or bonds from: Altus Labs; Micreos
    Other: Theraplex product with royalties; investor at LearnSkin

Editors

  • Briana Betz, PhD

    Medical Education Director
    Medscape, LLC

    Disclosures

    Disclosure: Briana Betz, PhD, has disclosed no relevant financial relationships.

  • Renata Feldman, PharmD

    Scientific Content Manager
    Medscape, LLC

    Disclosures

    Disclosure: Renata Feldman, PharmD, has disclosed no relevant financial relationships.

CME Reviewers

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Updates in Atopic Dermatitis From the Spring Allergy Meeting

Authors: Robert Sidbury, MD, MPH; Peter A. Lio, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME Released: 8/28/2020

Valid for credit through: 8/28/2021

processing....

Educational Impact Challenge

The goal of this activity is to educate physicians on the latest and emerging clinical data on the treatment of atopic dermatitis (AD) and the importance of treatment selection according to specific patient factors to improve patient care.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print